The incidence of severe neonatal hyperbilirubinemia is higher in Asians than in whites. A case-control study was designed to investigate the effects of eight known risk factors [breast feeding, ABO incompatibility, premature birth, infection, cephalohematoma, asphyxia, glucose-6-phosphate dehydrogenase (G6PD) deficiency, and variant UDP-glucuronosyltransferase 1A1 (UGT1A1) gene] and a suspicious analog [organic anion transporter 2 (OATP 2) gene] on severe hyperbilirubinemia in Taiwanese neonates. The 72 study subjects and 100 hospital control subjects consisted of neonates with peak serum bilirubin levels Ն342 M and Ͻ256.5 M, respectively. The PCR-restriction fragment length polymorphism method was applied to detect the UGT1A1, OATP 2, and G6PD genes. Bilirubin is mainly produced in its unconjugated form by the turnover of erythrocytes. It may be transported by the organic anion transporter 2 (OATP 2) (1), and it is then conjugated with glucuronic acid through reaction with UDP-glucuronosyltransferase 1A1 (UGT1A1) in the liver before being excreted into the bile (2). The bilirubin level in neonates is much higher than in adults because the life span of the erythrocytes is relatively short and the capacity for bilirubin elimination is lower than in adults (3). The peak serum levels of unconjugated bilirubin in full-term Asian and American-Indian neonates are double those in white and black populations (4). The incidence of severe hyperbilirubinemia and kernicterus is also higher among newborn Asian infants (3). These findings suggest that genetic factors may be involved in the development of severe neonatal hyperbilirubinemia.Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common genetic defect, affecting Ͼ400 million individuals worldwide (5). Furthermore, G6PD deficiency was the main risk factor for development of severe hyperbilirubinemia in Taiwanese neonates in the past (6). The situation has improved, however, since neonatal G6PD screening tests and health education were instituted at the Cathay General Hospital (CGH) in Taipei and nationwide in Taiwan in 1981 (7) and 1987 (6), respectively. Recently, another genetic defect, a variation in the promoter area or within the coding region of the UGT1A1 gene, was associated with neonatal hyperbilirubinemia in whites and in Japanese and Taiwanese, respectively (8 -12). It has been determined that the A(TA) 7 TAA promoter variant or homozygous G to A variation at nucleotide 211 in